+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Dysport"

From
Neurotoxin Market Report 2025 - Product Thumbnail Image

Neurotoxin Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Botulinum Toxin Market - Forecasts from 2025 to 2030 - Product Thumbnail Image

Botulinum Toxin Market - Forecasts from 2025 to 2030

  • Report
  • March 2025
  • 150 Pages
  • Global
From
From
From
From
From
Botulinum Toxin Market Report and Forecast 2023-2031 - Product Thumbnail Image

Botulinum Toxin Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
From
From
Market Spotlight: Neuropathic Pain - Product Thumbnail Image

Market Spotlight: Neuropathic Pain

  • Report
  • February 2021
  • 35 Pages
  • Global
Dysport - API Insight, 2022 - Product Thumbnail Image

Dysport - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
  • 20 Results (Page 1 of 1)
Loading Indicator

Dysport is a brand of botulinum toxin type A, a prescription medication used to treat certain neurological conditions. It is used to treat muscle spasms, excessive sweating, and wrinkles. Dysport is a competitor to Botox, another brand of botulinum toxin type A. Dysport is approved for use in more than 75 countries, including the United States, Canada, and the European Union. Dysport is a part of the Central Nervous System Drugs market, which includes medications used to treat neurological conditions. These drugs are used to treat a variety of conditions, including Parkinson's disease, multiple sclerosis, and epilepsy. Companies in the Dysport market include Ipsen, Merz Pharmaceuticals, and Galderma. Ipsen is the manufacturer of Dysport, while Merz Pharmaceuticals and Galderma are the distributors. Show Less Read more